HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 55 filers reported holding HILLEVAX INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $28,745,468 | -6.8% | 1,987,930 | +7.2% | 0.01% | -10.0% |
| Q1 2024 | $30,838,605 | +4.1% | 1,854,396 | +0.4% | 0.01% | -28.6% |
| Q4 2023 | $29,634,656 | +24.2% | 1,846,396 | +4.1% | 0.01% | +16.7% |
| Q3 2023 | $23,866,460 | +8.1% | 1,774,458 | +38.1% | 0.01% | +20.0% |
| Q2 2023 | $22,081,415 | +4.0% | 1,284,550 | 0.0% | 0.01% | -9.1% |
| Q1 2023 | $21,233,612 | +1.8% | 1,284,550 | +3.1% | 0.01% | 0.0% |
| Q4 2022 | $20,847,939 | +81.3% | 1,246,141 | +85.2% | 0.01% | +83.3% |
| Q3 2022 | $11,502,000 | +56.5% | 673,031 | +0.1% | 0.01% | +50.0% |
| Q2 2022 | $7,351,000 | – | 672,512 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 9,781,472 | $161,687,732 | 11.71% |
| Qiming U.S. Ventures Management, LLC | 558,923 | $9,238,997 | 11.18% |
| Samsara BioCapital, LLC | 609,862 | $10,081,019 | 2.08% |
| StepStone Group LP | 676,569 | $11,183,686 | 2.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,833,690 | $46,840,896 | 1.04% |
| Carlyle Group Inc. | 1,838,486 | $30,096,016 | 0.90% |
| BRAIDWELL LP | 1,620,216 | $26,782,170 | 0.88% |
| RA Capital Management | 1,760,019 | $29,093,114 | 0.66% |
| Perceptive Advisors | 406,024 | $6,711,577 | 0.20% |
| BVF INC/IL | 248,579 | $4,109,011 | 0.15% |